isatuximab,carfilzomib,dexamethasone
Sanofi,amgen
['ikema']
 presented sunset analysis of ikema. mpfs 25 vs 15 m in favor of isa-kd vs kd in early relapse group! #ash22 
UCSF Hematologist and BMT physician